[
    [
        {
            "time": "2021-05-31",
            "original_text": "乐普医疗回应新冠检测试剂在美被召回，还有这些产品曾遭“退货” 产品问题",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "新冠检测",
                    "FDA",
                    "召回",
                    "产品问题"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "乐普医疗回应新冠检测试剂在美被召回，还有这些产品曾遭“退货” 产品问题",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-01",
            "original_text": "FDA紧急召回乐普医疗两款新冠检测试剂产品：检测错误风险可能很高 产品问题",
            "features": {
                "keywords": [
                    "FDA",
                    "乐普医疗",
                    "召回",
                    "新冠检测",
                    "错误风险"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "FDA紧急召回乐普医疗两款新冠检测试剂产品：检测错误风险可能很高 产品问题",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-02",
            "original_text": "新冠检测产品被FDA召回，乐普医疗火速回应，专业人士：影响不大！",
            "features": {
                "keywords": [
                    "FDA",
                    "乐普医疗",
                    "召回",
                    "新冠检测",
                    "影响不大"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "新冠检测产品被FDA召回，乐普医疗火速回应，专业人士：影响不大！",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-03",
            "original_text": "国内疫情又见反复 新冠检测概念股集体飙涨",
            "features": {
                "keywords": [
                    "国内疫情",
                    "新冠检测",
                    "概念板块",
                    "飙涨"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国内疫情又见反复 新冠检测概念股集体飙涨",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-04",
            "original_text": "重大预警！700亿上海电气或损失83亿 上交所火线问询 乐普医疗也有“大事” 问询",
            "features": {
                "keywords": [
                    "上海电气",
                    "乐普医疗",
                    "问询",
                    "损失",
                    "预警"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "能源"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "重大预警！700亿上海电气或损失83亿 上交所火线问询 乐普医疗也有“大事” 问询",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]